Lu Wang

5.9k citations
187 papers · 3.7k · 1 hit paper · h-index 33

Impact in

Papers in

    • Circular RNAs in diseases 16
    • Metabolomics and Mass Spectrometry Studies 13
    • Epigenetics and DNA Methylation 12
    • MicroRNA in disease regulation 23
    • Cancer-related molecular mechanisms research 17

Lu Wang

175 papers receiving 3.6k citations

Lu Wang's Hit Papers

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression 2019 · 323 citations
3230+2+4Years since publication100200300

Peers

Lu Wang
Comparison fields: 5 of 169
  • Cancer Research 1.0k
  • Health, Toxicology and Mutagenesis 619
  • Pathology and Forensic Medicine 488
  • Molecular Biology 1.4k
  • Nutrition and Dietetics 298
Replace Li Su with:
Li Su China
Ulf Strömberg Sweden
Salvatore Panico Italy
Simona Iodice Italy
Qi‐Jun Wu China
John S. Witte United States
Yufang Bi China
Salvatore Santo Signorelli Italy
Erin Moshier United States
Steven D. Mark United States
Lu Wang relative to Li Su China Li Su's profile →
Citations per field
00.5×1.5×
Li Su · 1×
Citations per year

Countries citing papers authored by Lu Wang

Since Specialization
Citations

This map shows the geographic impact of Lu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wang more than expected).

Fields of papers citing papers by Lu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wang. The network helps show where Lu Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lu Wang Line = papers co-authored together Lu Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010390
2
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Hit paper breakdown →
2019323
3 2017111
4 2010104
5 200793
6
[A sero-epidemiological study on hepatitis C in China].
201180
7 201275
8 201375
9 201171
10 201769
11 201465
12 201562
13 201861
14 201860
15 201760
16 201559
17 201554
18 201451
19 201948
20 199348

About Lu Wang

Lu Wang is a scholar working on Molecular Biology, Cancer Research, Health, Toxicology and Mutagenesis, Oncology and Pathology and Forensic Medicine, having authored 187 papers that have together received 3.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Air Quality and Health Impacts (17 papers), Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (16 papers), Metabolomics and Mass Spectrometry Studies (13 papers), Climate Change and Health Impacts (12 papers), Epigenetics and DNA Methylation (12 papers) and Genetic Associations and Epidemiology (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Health, Toxicology and Mutagenesis (619 citations), Pathology and Forensic Medicine (488 citations), Molecular Biology (1.4k citations) and Nutrition and Dietetics (298 citations). Lu Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Hao Xu, Guangli Sun, Zekuan Xu, Weizhi Wang, Bowen Li, Zhipeng Xu, Zhongyuan He, Xiaoxu Huang, Feng Chen and Qing Li. Their work appears in journals such as Nutrients, Cancer Letters, Journal of Experimental & Clinical Cancer Research, Environmental Pollution and Frontiers in Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact